Literature DB >> 4067631

Recurring intracranial meningiomas. Evaluation of some factors predisposing for tumor recurrence.

D K Böker, H Meurer, F Gullotta.   

Abstract

60 cases of recurring meningiomas are analyzed in respect to factors influencing the risk of tumor recurrence. In our series of meningiomas operated on between 1970 and 1980 the recurrence rate was 9.5%. Recurrence rate was highest in tumors of the medial sphenoid. Incomplete tumor resection according to Simpson's grade III and IV lead to a higher recurrence rate than in grade I and II resection, but the difference is statistically not significant. Presence of mitoses, brain invasion and focal necrosis also is linked to a higher tumor recurrence rate. Tumors exhibiting all these three characteristics recurred in every case. Absence of lymphocytic tumor infiltration as a factor of risk is statistically not significant.

Entities:  

Mesh:

Year:  1985        PMID: 4067631

Source DB:  PubMed          Journal:  J Neurosurg Sci        ISSN: 0390-5616            Impact factor:   2.279


  14 in total

Review 1.  Tumors of the meninges: proposed modifications of the World Health Organization classification.

Authors:  B W Scheithauer
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  Factors influencing meningioma recurrence rate.

Authors:  M Naumann; J Meixensberger
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

Review 3.  Prognostic significance of brain invasion in meningiomas: systematic review and meta-analysis.

Authors:  Satoshi Nakasu; Yoko Nakasu
Journal:  Brain Tumor Pathol       Date:  2021-01-06       Impact factor: 3.298

4.  Predictors of Treatment Response and Survival Outcomes in Meningioma Recurrence with Atypical or Anaplastic Histology.

Authors:  Muhammad O Chohan; Christopher T Ryan; Ranjodh Singh; Ryan M Lanning; Anne S Reiner; Marc K Rosenblum; Viviane Tabar; Philip H Gutin
Journal:  Neurosurgery       Date:  2018-06-01       Impact factor: 4.654

5.  Diffusion Profiling via a Histogram Approach Distinguishes Low-grade from High-grade Meningiomas, Can Reflect the Respective Proliferative Potential and Progesterone Receptor Status.

Authors:  Georg Alexander Gihr; Diana Horvath-Rizea; Nikita Garnov; Patricia Kohlhof-Meinecke; Oliver Ganslandt; Hans Henkes; Hans Jonas Meyer; Karl-Titus Hoffmann; Alexey Surov; Stefan Schob
Journal:  Mol Imaging Biol       Date:  2018-08       Impact factor: 3.488

6.  Proliferative potential of meningiomas evaluated by proliferating cell nuclear antigen expression.

Authors:  H Nakabayashi; M Sakaguchi; J Katsuyama; A Hakuba
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

7.  18F-FDG PET in the assessment of tumor grade and prediction of tumor recurrence in intracranial meningioma.

Authors:  Jeong Won Lee; Keon Wook Kang; Sung-Hye Park; Sang Mi Lee; Jin Chul Paeng; June-Key Chung; Myung Chul Lee; Dong Soo Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04-18       Impact factor: 9.236

8.  Matrix metalloproteinase-2 and matrix metalloproteinase-9 expressions correlate with the recurrence of intracranial meningiomas.

Authors:  Masaki Okada; Keisuke Miyake; Yoshihito Matsumoto; Nobuyuki Kawai; Katsuzo Kunishio; Seigo Nagao
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

9.  Predicting the probability of meningioma recurrence in the preoperative and early postoperative period: a multivariate analysis in the midterm follow-up.

Authors:  Faruk Ildan; Tahsin Erman; A Iskender Göçer; Metin Tuna; Hüseyin Bağdatoğlu; Erdal Cetinalp; Refik Burgut
Journal:  Skull Base       Date:  2007-05

10.  The proliferation rate of intracranial tumors as defined by the monoclonal antibody KI 67. Application of the method to paraffin embedded specimens.

Authors:  D K Böker; H J Stark
Journal:  Neurosurg Rev       Date:  1988       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.